2 December 2020
Latham & Watkins Advises Underwriters in Intellia Therapeutics’ Public Offering of Common Stock
Advising firms
Deal team
4 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Peter Handrinos Lead | Latham & Watkins LLP | Partner | capital markets | Boston |
| Nathan Ajiashvili | Latham & Watkins LLP | Partner | capital markets | New York |
| Sandy Kugbei | Latham & Watkins LLP | Associate | capital markets | New York |
| Darby Dietrich | Latham & Watkins LLP | Associate | capital markets | New York |
1 more lawyer on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 175m (US$175 million)
- What the figure measures
- Issue size
- Client
- Not stated
- Counterparties
- Intellia Therapeutics, Inc. (Issuer)
Goldman Sachs & Co. LLC (Underwriters)
Jefferies (Underwriters)
SVB Leerink (Underwriters)